Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs

Clinica Chimica Acta

Volumn 304, Issue 1-2, 2001, Pages 39-47

  Massart, C ^a   Orgiazzi, J ^b   Maugendre, D ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Antithyroid drugs; Graves' disease; Human radioreceptor assay; TSH receptor antibody

Indexed keywords

CARBIMAZOLE; IMMUNOGLOBULIN; RECOMBINANT RECEPTOR; THYROGLOBULIN ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION CURVE; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RECEPTOR BINDING; RECURRENCE RISK; RELAPSE; REMISSION; REPRODUCIBILITY; SERUM; TREATMENT OUTCOME;

ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; CARBIMAZOLE; FEMALE; GRAVES DISEASE; HUMANS; MALE; RADIOLIGAND ASSAY; RECEPTORS, THYROTROPIN; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 0035150508     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00385-5     Document Type: Article

References (29)

1. Autoantibodies to the thyrotropin receptor
2. Thyroid stimulating immunoglobulins in Graves' disease
3. Relation of thyroid stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine and antithyroid drugs
4. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease
5. A sensitive technique for determination of thyroid-stimulating immunoglobulin (TSI) in unfractionated serum
6. Bioassay of thyroid-stimulating immunoglobulins using human thyroid cell cultures: Optimization and clinical assessment
7. An analysis of thyrotropin receptor binding and thyroid stimulating activities in a series of Graves' sera
8. Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease
9. Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease
10. Thyroid stimulating antibodies: An aid to the strategy of treatment of Graves' disease
11. The spectrum and significance of autoantibodies reacting with the thyrotropin receptor
12. The clinical use of thyrotropin receptor antibody measurements
13. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease
14. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells
15. Application of a bioassay with with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor
16. Use of Chinese hamster ovary cell lines transfected with cloned human thyrotropin receptor for the measurement of thyroid-stimulating antibodies: Advantages and difficulties
17. An improved radioceptor assay for TSH receptor antibodies
18. Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease
19. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies
20. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of antithyroid drugs
21. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies
22. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies
23. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
24. A new in vitro assay for human thyroid-stimulator using cultured thyroid cells: Effects of sodium chloride on adenosine 3′,5′-monophosphate increase
25. Receiver-operating characteristic ROC plots: A fundamental evaluation tool in clinical medicine
26. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor
27. Therapeutic controversy. Thyroid controversy - Stimulating antibodies
28. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies of Graves' disease